Tech Company Financing Transactions

Science 37 Funding Round

Science 37, based in Los Angeles, secured $29 million in investment from Glynn Capital Management, Amgen Ventures and dRx Capital.

Transaction Overview

Company Name
Science 37
Announced On
4/26/2017
Transaction Type
Venture Equity
Amount
$29,000,000
Round
Series C
Investors

Glynn Capital Management (Lead Investor) (Scott Jordon)

Amgen Ventures

dRx Capital (Lucian Iancovici)

GV (Krishna Yeshwant)

Lux Capital (Adam Goulburn)

Redmile Group (Rob Faulkner)

Sanofi-Genzyme BioVentures

Proceeds Purpose
The round will also allow us to expand into new therapeutic areas and to introduce these trials to a much broader set of demographics, including those with limited access to major medical facilities where these trials are typically offered.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
12121 Bluff Creek Dr. 100
Los Angeles, CA 90094
USA
Phone
(984) 377-3737
Website
www.science37.com
Email Address
[email protected]
Overview
At Science 37, we don't see diseases, we see people -- the patients who are suffering and the physician-scientists trying to help. S37 was created to help patients access the most advanced research available to help with their health problems.
Profile
Science 37 LinkedIn Company Profile
Social Media
Science 37 Company Twitter Account
Company News
Science 37 News
Facebook
Science 37 on Facebook
YouTube
Science 37 on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Coman
  David Coman LinkedIn Profile  David Coman Twitter Account  David Coman News  David Coman on Facebook
Chief Financial Officer
Michael Zaranek
  Michael Zaranek LinkedIn Profile  Michael Zaranek Twitter Account  Michael Zaranek News  Michael Zaranek on Facebook
Chief Medical Officer
Jonathan Cotliar
  Jonathan Cotliar LinkedIn Profile  Jonathan Cotliar Twitter Account  Jonathan Cotliar News  Jonathan Cotliar on Facebook
Vice President
Jonathan Commons
  Jonathan Commons LinkedIn Profile  Jonathan Commons Twitter Account  Jonathan Commons News  Jonathan Commons on Facebook
Vice President
Darcy Forman
  Darcy Forman LinkedIn Profile  Darcy Forman Twitter Account  Darcy Forman News  Darcy Forman on Facebook
VP - Administration
Adriana Centeno
  Adriana Centeno LinkedIn Profile  Adriana Centeno Twitter Account  Adriana Centeno News  Adriana Centeno on Facebook
VP - Bus. Development
Steve Geffon
  Steve Geffon LinkedIn Profile  Steve Geffon Twitter Account  Steve Geffon News  Steve Geffon on Facebook
VP - General Counsel
Laura Podolsky
  Laura Podolsky LinkedIn Profile  Laura Podolsky Twitter Account  Laura Podolsky News  Laura Podolsky on Facebook
VP - Product Management
Chris Ceppi
  Chris Ceppi LinkedIn Profile  Chris Ceppi Twitter Account  Chris Ceppi News  Chris Ceppi on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/26/2017: Deck Commerce venture capital transaction
Next: 4/26/2017: Nutriati venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.